Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
317.31
+0.20 (0.06%)
Oct 6, 2026, 1:46 PM EDT - Market open
Penumbra Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,505 | 1,404 | 1,195 | 1,059 | 847.13 | 747.59 |
Revenue Growth | 17.55% | 17.50% | 12.86% | 24.95% | 13.31% | 33.40% |
Gross Profit Gross Profit Growth | 1,021 | 942.44 | 788.36 | 682.64 | 535.21 | 475.38 |
Operating Income Operating Income Growth | 187.34 | 189.25 | 119.59 | 91.77 | 6.08 | -7.5 |
Net Income Net Income Growth | 160.59 | 177.69 | 14.01 | 90.95 | -2 | 5.28 |
Earnings Per Share EPS Growth | 4.07 | 4.52 | 0.36 | 2.32 | -0.05 | 0.14 |
EPS Growth | 8.81% | 1155.56% | -84.48% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Thrombectomy Thrombectomy Growth | 1,004 | 947.92 | 815.48 | 677.34 | 511.14 | 437.78 |
Embolization and Access Embolization and Access Growth | 500.86 | 455.75 | 379.14 | 381.18 | 336 | 309.82 |
Revenue (Total) Revenue (Total) Growth | 1,505 | 1,404 | 1,195 | 1,059 | 847.13 | 747.59 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 658.8 | 544.82 | 340.13 | 289.19 | 188.03 | 254.88 |
Total Debt Total Debt Growth | 212.71 | 219.7 | 223.39 | 234.34 | 235.77 | 173.55 |
Net Cash (Debt) Net Cash Growth | 446.09 | 325.12 | 116.74 | 54.84 | -47.74 | 81.33 |
Net Cash Growth | 118.63% | 178.49% | 112.86% | - | - | -56.64% |
Net Cash Per Share Net Cash Per Share Growth | 11.30 | 8.27 | 2.97 | 1.40 | -1.26 | 2.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 277.8 | 238.66 | 168.48 | 97.33 | -55.66 | 9.5 |
Capital Expenditures CapEx Growth | -61.9 | -63.73 | -21.18 | -16.2 | -19.3 | -21.18 |
Free Cash Flow Free Cash Flow Growth | 215.91 | 174.93 | 147.3 | 81.13 | -74.96 | -11.68 |
Free Cash Flow Growth | 33.59% | 18.76% | 81.56% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 67.84% | 67.14% | 65.99% | 64.49% | 63.18% | 63.59% |
Operating Margin | 12.45% | 13.48% | 10.01% | 8.67% | 0.72% | -1.00% |
Pretax Margin | 13.54% | 14.61% | 1.75% | 7.52% | 0.46% | -1.40% |
Profit Margin | 10.67% | 12.66% | 1.17% | 8.59% | -0.24% | 0.71% |
FCF Margin | 14.35% | 12.46% | 12.33% | 7.66% | -8.85% | -1.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 78.12 | 68.52 | 650.46 | 106.74 | - | 2031.40 |
Forward PE | 57.17 | 66.33 | 66.15 | 93.34 | 298.52 | 231.90 |
P/FCF Ratio | 57.95 | 69.60 | 61.88 | 119.66 | - | - |
PS Ratio | 8.31 | 8.67 | 7.63 | 9.17 | 9.97 | 14.36 |